Genmab Announces that Janssen has Received Positive CHMP Opinion for RYBREVANT® (amivantamab) for Patients with Advanced Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations, After Failure of Platinum-based Therapy

Written by Customer Service on October 15, 2021. Posted in Public Companies.

Media Release Copenhagen, Denmark, October 15, 2021 Janssen-Cilag International NV (Janssen) received a positive CHMP opinion recommending conditional marketing authorization of amivantamab in Europe for the treatment of adult patients with advanced non-small cell lung cancer with activating epidermal growth factor receptor exon 20 insertion mutations, after failure of platinum-based therapy Represents First CHMP opinion for a DuoBody® product candidate Genmab A/S (Nasdaq: GMAB) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended the granting of a conditional marketing authorization in Europe for Janssen’s amivantamab, a fully human bispecific antibody, for the treatment of adult patients with advanced non-small cell lung...

Disclosure of received notification of The Capital Group Companies and NN Group NV

Written by Customer Service on October 15, 2021. Posted in Public Companies.

Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 15 October 2021 Disclosure of received notification of The Capital Group Companies and NN Group NV Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron received notifications of The Capital Group Companies, Inc. (“CGC”) and NN Group NV Notification of The Capital Group Companies, Inc. On 14 October 2021, Fagron received a notification that the shareholding of CGC had fallen below the disclosure threshold of 5% on 13 October 2021, as the result of the disposal of voting securities or voting rights. The notification is made by a ‘parent undertaking or a controlling person’. On 13 October 2021, CGC held a total of 2,788,420 voting rights. 1,484,803 voting rights are held by Capital Research and Management...

Comstock’s BLVD Gramercy East Wins Delta Associates Award for Excellence

Written by Customer Service on October 15, 2021. Posted in Public Companies.

Newest Addition to Comstock’s Luxury Residential Portfolio located in Loudoun Station RESTON, Va., Oct. 15, 2021 (GLOBE NEWSWIRE) — Comstock Holdings Companies, Inc. (NASDAQ: CHCI) is pleased to announce that BLVD Gramercy East has been selected as “Best Washington/Baltimore Mid-Rise Apartment Community” at the Delta Associate’s 25th Annual Apartment and Condominium Industry Awards for Excellence. For the last twenty-five years, Delta Associate’s has presented awards for excellence in the DMV recognizing outstanding accomplishments in the multifamily industry. BLVD Gramercy East is located at Loudoun Station, Loudoun County’s only transit-oriented community adjacent to Metro’s Ashburn Station on the Silver Line. BLVD Gramercy East is a pet-friendly residential development with a range of studio, one-, two-, and three-bedroom rentals,...

Melcor REIT announces October, November and December distribution of $0.04 per unit; announces Q3-2021 conference call details

Written by Customer Service on October 15, 2021. Posted in Dividend Reports And Estimates.

EDMONTON, Alberta, Oct. 15, 2021 (GLOBE NEWSWIRE) — Melcor Real Estate Investment Trust (TSX: MR.UN) today announced that the Trustees of the REIT have declared cash distributions of $0.04 per unit for the months of October, November and December 2021, unchanged from previous months. The October, November and December distributions will be payable as follows: Month Record Date Distribution Date Distribution Amount October 2021 October 29, 2021 November 15, 2021 $0.04 per unit November 2021 November 30, 2021 December 15, 2021 $0.04 per unit December 2021 December 31, 2021 January 17, 2022 $0.04 per unit Melcor REIT also announced that results for the third quarter ended September 30, 2021 will be released on November 2, 2021 after market close. Management will host a conference call at 11:00 am ET (9:00 am MT) on Wednesday,...

Freddie Mac: Strong Housing Market will Continue even as Rates and Prices Rise

Written by Customer Service on October 15, 2021. Posted in Public Companies.

Freddie Mac Releases Quarterly Forecast Forecast Snapshot October 2021 MCLEAN, Va., Oct. 15, 2021 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today predicted the continued strength of the single-family housing market even as mortgage rates are expected to modestly increase and home prices rise. A new Quarterly Forecast released by the company’s Chief Economist estimates continued levels of homebuyer demand and a growth in purchase originations in 2022. “Despite some obvious headwinds, the housing market remains strong as the economy grows,” said Sam Khater, Freddie Mac’s Chief Economist. “Even as mortgage rates are expected to increase and home prices continue to rise, homebuyer demand remains steady as inventory issues have slightly improved.” Khater continued, “Therefore, in 2022, we expect strong house price...

US FDA approves Roche’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer

Written by Customer Service on October 15, 2021. Posted in Public Companies.

Tecentriq is the first and only cancer immunotherapy approved for NSCLC in the adjuvant setting Approval is based on the Phase III IMpower010 study showing adjuvant Tecentriq improved disease-free survival by more than one-third in PD-L1-positive Stage II-IIIA lung cancer, compared with best supportive care Basel, 15 October 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) as adjuvant treatment, following surgery and platinum-based chemotherapy, for adults with Stage II-IIIA non-small cell lung cancer (NSCLC) whose tumours express PD-L1≥1%, as determined by an FDA-approved test. “Tecentriq is now the first and only cancer immunotherapy available for adjuvant treatment of NSCLC, introducing a new era where people diagnosed with early lung...

Amlan International to Showcase Health and Performance Benefits of Mineral-Based Feed Additives at Leman China Swine Conference

Written by Customer Service on October 15, 2021. Posted in Public Companies.

CHICAGO, Oct. 16, 2021 (GLOBE NEWSWIRE) — At the upcoming 10th Leman China Swine Conference and 2021 World Swine Industry Expo, Amlan International will highlight how its natural, mineral-based feed additives are improving intestinal health in swine and helping producers overcome key economic production challenges. The conference and expo, to be held on October 20-22, 2021, in the Chongqing International Expo Center, are expected to attract approximately 6,000 conference attendees and more than 50,000 expo visitors. As the animal health business of Oil-Dri® Corporation of America, Amlan International’s scientifically proven products are backed by Oil-Dri’s 80 years of experience in mineral science. Amlan’s scientists use Oil-Dri’s mineral expertise to develop reliable, research-backed products that improve the quality and safety...

Litigation with Unleashed Entertainment LLC Dismissed

Written by Customer Service on October 15, 2021. Posted in Public Companies.

Denver, CO, Oct. 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — CBD Global Sciences, Inc. (OTC: CBDNF) (CSE: CBDN) (Frankfurt:GS3), (“CBD Global” or the “Company”) is pleased to announce that the previously announced litigation with Unleashed Entertainment LLC has been dismissed with prejudice and with no payment of damages or other remuneration to the Plaintiff. Case No. 1:21-cv-928 filed in federal court against CBD Global Sciences was dismissed October 14th, 2021, six and a half months after being filed. Brad Wyatt, CEO of CBD Global Sciences, shared, “We are happy to be able to refocus our attention on productive activities and put this behind us. A distraction of this magnitude created uncertainty for our shareholders and diverted precious time and resources. With this now behind us, we will focus our team’s attention...

ALSTOM SA : Alstom to supply new trams for the T1-Line in the Ile-de-France region

Written by Customer Service on October 15, 2021. Posted in Public Companies.

Alstom to supply new trams for the T1-Line in the Ile-de-France region Ile-de-France Mobilités and RATP have placed an order with Alstom for 37 Citadis X05 tramways. An optional tranche of 83 tramways is also planned, i.e. a contract comprising a maximum of 120 tramways in total. These new tramways, which will be used to renew the T1-Line in the Ile-de-France region, will optimise transport capacity (+15%) and passenger comfort. 15 October 2021 – Alstom has been chosen by Ile-de-France Mobilités and RATP to supply the new trams for the T1-Line in the Ile-de-France region. The firm order, for 37 Citadis X05 tramways worth around 130 million euro, is to replace the current trams. An optional tranche of 83 tramways is also planned in order to reinforce the transport offer and meet the needs related to the extension of the line. “Alstom...

Exela Technologies Expands Relationship with a Leading Health Maintenance Organization (HMO)

Written by Customer Service on October 15, 2021. Posted in Public Companies.

Enterprise Digital Mailroom (DMR) deployment to facilitate digital communication to service HMO’s 200,000 members Demand for DMR platform continues across both enterprise customers and the SMB market segment IRVING, Texas, Oct. 15, 2021 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or “the Company”) (NASDAQ: XELA), a global business process automation leader, today announced an expansion with a leading Medicare Advantage HMO. This expansion highlights the continued demand for Exela’s DMR platform to facilitate digital communication. Exela’s DMR is an end-to-end document management system that digitizes mail and other documents to create searchable, shareable digital assets that can be automatically routed to individual or group recipients, fully tracked, and made accessible via a secure web-based portal, from anywhere...

Day: October 15, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice